John Thomas Replay
March 16, 2023Please note: If the video is not showing on this page - wait a moment for it to appear OR hit refresh.
Why it’s Time to Buy the Dip on Biotech and Health Care
- A new generation of obesity drugs is creating a $150 billion a year market
- The safest sector in the market has recently been completely ignored in a post pandemic world
- We are on the precipice of major breakthrough discoveries at almost every company
- The first leg of a new bull market in biotech is just ahead of us
- Many stocks will rise by a multiple from here
- Learn how to make big money in biotech and save your own life along the way
- Join the man who made 87% in 2022 and 30% so far in 2023
- Sign up with the greatest money manager of our generation